Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Acquired reactive perforating collagenosis, characterized by pruritic eruptions and systemic associations, often manifests in patients with diabetes or chronic kidney disease, underscoring the necessity for holistic patient assessment in dermatological evaluations.
Dermatology April 15th 2024
In patients with end-stage kidney disease, extraosseous calcification presents a complex clinical challenge, involving an active process with significant implications for patient management and outcomes. Understanding its pathogenesis and treatment options is crucial for optimizing care.
Nephrology April 9th 2024
In patients with chronic kidney disease, the elevated troponin challenge necessitates a nuanced approach, integrating serial measurements and clinical context to discern acute coronary syndrome from chronic elevations, thereby informing targeted management strategies.
Cardiology April 9th 2024
GoodRx Health
Urine color can serve as a valuable diagnostic tool, offering insights into a patient’s hydration level and potential underlying health issues. Understanding these variations is essential for timely and accurate diagnosis.
Urology April 8th 2024
SGLT-2 inhibitors have emerged as a cornerstone in managing HFrEF and CKD, demonstrating substantial reductions in cardiovascular and renal adverse outcomes. This class of medications is reshaping the therapeutic approach in patients with these comorbid conditions, providing a dual benefit that was once considered challenging to achieve.
Cardiology April 8th 2024
Annals of Internal Medicine
In a recent study assessing chronic insomnia treatments in hemodialysis patients, no significant difference was observed between CBT-I, trazodone, and placebo in improving Insomnia Severity Index scores. This highlights a critical need for alternative therapeutic approaches in this unique patient population.
Nephrology January 24th 2024